186 results
Page 4 of 10
6-K
EX-99.7
xw076m 1ct45ukhcq80
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.2
0o146br3knc agiq
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.3
bgdmn5f55cf6 zg37ys7
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.1
k8zrb5xr j3
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.3
4wk11o96pw9n ab081d
13 Aug 21
RepliCel Life Sciences Announces Debt Settlement
12:00am
6-K
EX-99.2
wlnygxd9 97d9lct1cw
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.1
9cksjr5r
13 Aug 21
RepliCel Life Sciences Announces Debt Settlement
12:00am
6-K
EX-99.2
580aq
13 Aug 21
51-102F3 Material Change Report
12:00am
6-K
EX-99.2
3kmzi6w
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
6-K
EX-99.1
nswzl25r
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
20-F/A
ktpwds1c
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.5
e2qyxf kuetyr
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.2
lrgjc7mv9kurx bk
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.1
vf8llopicbo46m
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.2
uvh1gurtihz2rk7f
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.3
t1htts6je9lgdrpi
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.2
s6tf3y
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm
6-K
EX-99.1
k4x r2fdy2hkc
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm